Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Inhibition of IL-17 signaling in macrophages underlies the anti-arthritic effects of halofuginone hydrobromide: Network pharmacology, molecular docking, and experimental validation

Fig. 4

Protein–protein interaction (PPI) network construction of the target proteins of HF against RA. (A) PPI network and key core targets screening. The more connections, the stronger the correlation with the therapeutic target. The larger the DC, the larger the label font size and the darker the color. The larger the BC, the wider the circle. (B) Detailed information on the topological networks of the top 10 targets

Back to article page